Five-year grant supports research on nanoparticles’ design on inflammatory responses

Award from the Maryland Industrial Partnerships (MIPS) program supports work to formulate Clofazimine for treatment of recurrent C. difficile infections.

New center established by the School of Pharmacy, in collaboration with the University of Michigan, will increase access to safe and effective generic drugs through collaborative research, training, and exchange.

Meeting brings together 360 stakeholders from across academia, government, and industry to explore methods to develop better models that can identify and accurately predict drug risks and efficacy.

Information about the molecular shape of the viruses that cause COVID-19, SARS, and MERS reveals structural similarities that suggest possible drug treatments.

Virtual event brings together more than 500 attendees, including stakeholders from the FDA, academia, and industry.

New non-invasive quality assurance method developed by Dr. Bruce Yu and his team offers more effective way to detect freezing events in vaccines at the point-of-care.

Peter Swaan, PhD, succeeds Paul Shapiro, PhD, as chair of the Department of Pharmaceutical Sciences at the University of Maryland School of Pharmacy.

Ralph Blomster, PhD, is remembered for his more than 40 years of service to the School.

Biennial event facilitates scientific exchange and interactive communication among students, postdoctoral fellows, and faculty from two of Baltimore’s premier academic institutions.

Event organized by the School’s Metallotherapeutics Research Center brings together regional experts with interest in metal systems to stimulate interaction and collaboration.

Day-long event provides glimpses into potential careers for students and allows alumni to reconnect with faculty and one another.